Rank | Gene Set | Z-score |
---|---|---|
1 | pattern specification involved in kidney development (GO:0061004) | 7.87921896 |
2 | cellular response to nitric oxide (GO:0071732) | 6.71759279 |
3 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.49836736 |
4 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.33194072 |
5 | response to xenobiotic stimulus (GO:0009410) | 5.96974768 |
6 | lung lobe morphogenesis (GO:0060463) | 5.56418589 |
7 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.56348833 |
8 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.54640742 |
9 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.53019109 |
10 | T-helper 1 type immune response (GO:0042088) | 5.47849625 |
11 | positive regulation of type 2 immune response (GO:0002830) | 5.44690896 |
12 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 5.29969872 |
13 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.28845471 |
14 | cellular response to reactive nitrogen species (GO:1902170) | 5.21948773 |
15 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.20777429 |
16 | phosphate ion transmembrane transport (GO:0035435) | 5.08750836 |
17 | regulation of endothelial cell differentiation (GO:0045601) | 5.00883714 |
18 | response to nitric oxide (GO:0071731) | 4.95935273 |
19 | respiratory gaseous exchange (GO:0007585) | 4.88040093 |
20 | endothelial tube morphogenesis (GO:0061154) | 4.87625884 |
21 | morphogenesis of an endothelium (GO:0003159) | 4.87625884 |
22 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.86979794 |
23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.81227994 |
24 | trivalent inorganic anion homeostasis (GO:0072506) | 4.75260647 |
25 | phosphate ion homeostasis (GO:0055062) | 4.75260647 |
26 | cellular response to type I interferon (GO:0071357) | 4.74614474 |
27 | type I interferon signaling pathway (GO:0060337) | 4.74614474 |
28 | regulation of chronic inflammatory response (GO:0002676) | 4.71720980 |
29 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.71126014 |
30 | response to type I interferon (GO:0034340) | 4.70561063 |
31 | sodium-independent organic anion transport (GO:0043252) | 4.69606308 |
32 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.68089597 |
33 | regulation of T cell tolerance induction (GO:0002664) | 4.58754149 |
34 | cellular anion homeostasis (GO:0030002) | 4.56023784 |
35 | regulation of T-helper cell differentiation (GO:0045622) | 4.54577758 |
36 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.53171211 |
37 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.48142766 |
38 | positive regulation of interleukin-12 production (GO:0032735) | 4.47613188 |
39 | negative regulation of interleukin-10 production (GO:0032693) | 4.45782419 |
40 | regulation of antigen processing and presentation (GO:0002577) | 4.43432512 |
41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.34639276 |
42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.24216346 |
43 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.18396783 |
44 | phosphate ion transport (GO:0006817) | 4.17597802 |
45 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.17357151 |
46 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 4.15236601 |
47 | positive regulation of tolerance induction (GO:0002645) | 4.14520172 |
48 | regulation of interleukin-12 production (GO:0032655) | 4.11208487 |
49 | regulation of vasculogenesis (GO:2001212) | 4.09955555 |
50 | peptide catabolic process (GO:0043171) | 4.05740532 |
51 | regulation of tolerance induction (GO:0002643) | 3.99675807 |
52 | virion attachment to host cell (GO:0019062) | 3.99649071 |
53 | adhesion of symbiont to host cell (GO:0044650) | 3.99649071 |
54 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.98330578 |
55 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.97746927 |
56 | regulation of T-helper 1 type immune response (GO:0002825) | 3.95481121 |
57 | mesodermal cell differentiation (GO:0048333) | 3.85905922 |
58 | macrophage chemotaxis (GO:0048246) | 3.85226335 |
59 | negative regulation of interleukin-12 production (GO:0032695) | 3.81707747 |
60 | protein localization to endosome (GO:0036010) | 3.79330191 |
61 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.78503416 |
62 | negative regulation of interleukin-2 production (GO:0032703) | 3.77694496 |
63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.76807155 |
64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.75412091 |
65 | defense response to protozoan (GO:0042832) | 3.75307052 |
66 | NIK/NF-kappaB signaling (GO:0038061) | 3.73925175 |
67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.70373515 |
68 | regulation of interferon-alpha production (GO:0032647) | 3.68005085 |
69 | positive regulation of interleukin-10 production (GO:0032733) | 3.63960075 |
70 | regulation of interleukin-10 production (GO:0032653) | 3.60978003 |
71 | regulation of type 2 immune response (GO:0002828) | 3.60820300 |
72 | segment specification (GO:0007379) | 3.59020607 |
73 | lung vasculature development (GO:0060426) | 3.58214223 |
74 | kynurenine metabolic process (GO:0070189) | 3.58167895 |
75 | lung alveolus development (GO:0048286) | 3.57040575 |
76 | establishment of apical/basal cell polarity (GO:0035089) | 3.54052558 |
77 | immunoglobulin mediated immune response (GO:0016064) | 3.53804020 |
78 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.52584616 |
79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51172674 |
80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50669644 |
81 | response to protozoan (GO:0001562) | 3.50293943 |
82 | positive regulation of defense response to virus by host (GO:0002230) | 3.48930864 |
83 | positive regulation of interferon-alpha production (GO:0032727) | 3.47074642 |
84 | cellular response to interferon-gamma (GO:0071346) | 3.46152879 |
85 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.44729671 |
86 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.44283402 |
87 | blood vessel maturation (GO:0001955) | 3.43792672 |
88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.42611442 |
89 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.42193541 |
90 | tryptophan catabolic process (GO:0006569) | 3.40099898 |
91 | indole-containing compound catabolic process (GO:0042436) | 3.40099898 |
92 | indolalkylamine catabolic process (GO:0046218) | 3.40099898 |
93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.40051248 |
94 | T cell migration (GO:0072678) | 3.38299669 |
95 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37380581 |
96 | sphingosine metabolic process (GO:0006670) | 3.37288495 |
97 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.36249339 |
98 | dendritic cell differentiation (GO:0097028) | 3.36083203 |
99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35571326 |
100 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.33833079 |
101 | response to interferon-gamma (GO:0034341) | 3.33645478 |
102 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.32645343 |
103 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.32426171 |
104 | positive regulation of neutrophil migration (GO:1902624) | 3.32426171 |
105 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.31874628 |
106 | adhesion of symbiont to host (GO:0044406) | 3.31748427 |
107 | glomerular epithelial cell development (GO:0072310) | 3.31324870 |
108 | response to peptidoglycan (GO:0032494) | 3.29666419 |
109 | positive regulation of interleukin-17 production (GO:0032740) | 3.29552308 |
110 | hemidesmosome assembly (GO:0031581) | 3.27392405 |
111 | macrophage activation involved in immune response (GO:0002281) | 3.27107502 |
112 | respiratory tube development (GO:0030323) | 3.26582179 |
113 | branch elongation of an epithelium (GO:0060602) | 3.25499290 |
114 | sodium ion homeostasis (GO:0055078) | 3.25275155 |
115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.24719961 |
116 | natural killer cell activation involved in immune response (GO:0002323) | 3.23746148 |
117 | endocardial cushion development (GO:0003197) | 3.22945839 |
118 | regulation of memory T cell differentiation (GO:0043380) | 3.22887736 |
119 | dendritic cell chemotaxis (GO:0002407) | 3.19924415 |
120 | lung secretory cell differentiation (GO:0061140) | 3.19822985 |
121 | germinal center formation (GO:0002467) | 3.18735301 |
122 | negative regulation of fatty acid transport (GO:2000192) | 3.17749268 |
123 | regulation of glomerular filtration (GO:0003093) | 3.15208346 |
124 | myeloid dendritic cell differentiation (GO:0043011) | 3.14620658 |
125 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.14329425 |
126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13813473 |
127 | negative regulation of cell killing (GO:0031342) | 3.13813473 |
128 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.13691395 |
129 | response to vitamin A (GO:0033189) | 3.13315758 |
130 | Leydig cell differentiation (GO:0033327) | 3.13164958 |
131 | axis elongation (GO:0003401) | 3.11977405 |
132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09834290 |
133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09375970 |
134 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09371093 |
135 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09371093 |
136 | modulation by symbiont of host immune response (GO:0052553) | 3.09371093 |
137 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09371093 |
138 | modulation by symbiont of host defense response (GO:0052031) | 3.09371093 |
139 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09371093 |
140 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.08630741 |
141 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.08365189 |
142 | response to hyperoxia (GO:0055093) | 3.07775227 |
143 | response to increased oxygen levels (GO:0036296) | 3.07775227 |
144 | lymphangiogenesis (GO:0001946) | 3.06625501 |
145 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.06559087 |
146 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.05647834 |
147 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.04493209 |
148 | negative regulation of viral genome replication (GO:0045071) | 3.03514702 |
149 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.02970847 |
150 | response to interleukin-6 (GO:0070741) | 3.02864442 |
151 | sexual reproduction (GO:0019953) | 3.01829563 |
152 | establishment of monopolar cell polarity (GO:0061162) | 3.01709223 |
153 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.01709223 |
154 | embryonic foregut morphogenesis (GO:0048617) | 3.01700222 |
155 | cell adhesion mediated by integrin (GO:0033627) | 3.01567821 |
156 | regulation of interleukin-13 production (GO:0032656) | 3.00424982 |
157 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.00384772 |
158 | glomerular visceral epithelial cell development (GO:0072015) | 3.00319294 |
159 | surfactant homeostasis (GO:0043129) | 20.1634683 |
160 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97897070 |
161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.95370449 |
162 | regulation of hypersensitivity (GO:0002883) | 2.94942532 |
163 | receptor catabolic process (GO:0032801) | 2.93287374 |
164 | lymphocyte chemotaxis (GO:0048247) | 2.92584729 |
165 | negative regulation of interleukin-17 production (GO:0032700) | 2.92477688 |
166 | diol metabolic process (GO:0034311) | 2.91727666 |
167 | regulation of hippo signaling (GO:0035330) | 2.90996539 |
168 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.90370366 |
169 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.88933594 |
170 | T-helper cell differentiation (GO:0042093) | 2.88933594 |
171 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.87541731 |
172 | positive regulation of humoral immune response (GO:0002922) | 2.87045051 |
173 | positive regulation of vasculogenesis (GO:2001214) | 2.86608722 |
174 | regulation of alpha-beta T cell activation (GO:0046634) | 2.86061907 |
175 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.80457342 |
176 | endothelial cell chemotaxis (GO:0035767) | 2.79102090 |
177 | lung-associated mesenchyme development (GO:0060484) | 2.71546626 |
178 | triglyceride biosynthetic process (GO:0019432) | 2.70993096 |
179 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.70808171 |
180 | positive regulation of p38MAPK cascade (GO:1900745) | 2.70148466 |
181 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.68970032 |
182 | hormone catabolic process (GO:0042447) | 2.67473526 |
183 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.66991667 |
184 | artery development (GO:0060840) | 2.65302135 |
185 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.61360058 |
186 | neutral lipid biosynthetic process (GO:0046460) | 2.60344487 |
187 | acylglycerol biosynthetic process (GO:0046463) | 2.60344487 |
188 | negative regulation of cell fate specification (GO:0009996) | 2.55850240 |
189 | renal system process involved in regulation of blood volume (GO:0001977) | 2.53508342 |
190 | gas transport (GO:0015669) | 2.52768526 |
191 | renal filtration (GO:0097205) | 2.52149585 |
192 | lateral sprouting from an epithelium (GO:0060601) | 2.51758304 |
193 | mesenchymal cell proliferation (GO:0010463) | 2.50432538 |
194 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.50052162 |
195 | negative regulation of epithelial to mesenchymal transition (GO:0010719) | 2.49806839 |
196 | regulation of cardioblast differentiation (GO:0051890) | 2.49015877 |
197 | chemical homeostasis within a tissue (GO:0048875) | 16.1695642 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.75702444 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.83480846 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.78328479 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.46487987 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.99265469 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73966019 |
7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.61281961 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58066745 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01854523 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.94565262 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.79281433 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78303715 |
13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.75971698 |
14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.75657264 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.75615123 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73718913 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59662184 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55518803 |
19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46161258 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.43931612 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31541191 |
22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.29730121 |
23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.27970641 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25942590 |
25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22462273 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18349212 |
27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12617770 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12332951 |
29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12230542 |
30 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.07955450 |
31 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.06540881 |
32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05529268 |
33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.02129770 |
34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.01577148 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98639040 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98057654 |
37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88307629 |
38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.86981269 |
39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85743251 |
40 | MYB_26560356_Chip-Seq_TH2_Human | 1.83446901 |
41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71814986 |
42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.67548732 |
43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.64587896 |
44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64039323 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63403188 |
46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61759398 |
47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.60719196 |
48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60178653 |
49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58533886 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58391517 |
51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58307626 |
52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.58275721 |
53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.58275721 |
54 | MAF_26560356_Chip-Seq_TH1_Human | 1.58207532 |
55 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55415755 |
56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.54585523 |
57 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.54190987 |
58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51823760 |
59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50902810 |
60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.50174130 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49284725 |
62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47230892 |
63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45765696 |
64 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.45041108 |
65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43282371 |
66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42470352 |
67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42171638 |
68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41740378 |
69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41339815 |
70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40508975 |
71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40449096 |
72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39215886 |
73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38951513 |
74 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.38926004 |
75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37543507 |
76 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36917258 |
77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36802885 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34874442 |
79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33984299 |
80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33665440 |
81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33471503 |
82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33001090 |
83 | * MYB_26560356_Chip-Seq_TH1_Human | 1.32828387 |
84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29048789 |
85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28489402 |
86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28434685 |
87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28402425 |
88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27923239 |
89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25291794 |
90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24584217 |
91 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23954799 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23683333 |
93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23140932 |
94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23071432 |
95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20715291 |
96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20715291 |
97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16982521 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16892576 |
99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16304663 |
100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15921847 |
101 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.15512174 |
102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15401403 |
103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12431274 |
104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10429229 |
105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09654389 |
106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09323030 |
107 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09164876 |
108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08661259 |
109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08514711 |
110 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05244679 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05179842 |
112 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04535164 |
113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04452987 |
114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04345725 |
115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04318205 |
116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04308960 |
117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03331785 |
118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03205825 |
119 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02953945 |
120 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01241942 |
121 | MYC_22102868_ChIP-Seq_BL_Human | 1.00923750 |
122 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.00766683 |
123 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99679227 |
124 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99648108 |
125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98462889 |
126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98342190 |
127 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97121887 |
128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96729278 |
129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96536659 |
130 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96297000 |
131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95193444 |
132 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94136179 |
133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94016241 |
134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91866038 |
135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91774838 |
136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91320436 |
137 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90319070 |
138 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89972482 |
139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88871681 |
140 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88483016 |
141 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88329045 |
142 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88202640 |
143 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88154330 |
144 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84633081 |
145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84494786 |
146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83682394 |
147 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82344823 |
148 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81656015 |
149 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81107041 |
150 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80004337 |
151 | MAF_26560356_Chip-Seq_TH2_Human | 0.77071590 |
152 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76508081 |
153 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75338164 |
154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75270975 |
155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74202948 |
156 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.73711272 |
157 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.73711272 |
158 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.73711272 |
159 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73330233 |
160 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73297332 |
161 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72928057 |
162 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69894301 |
163 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69341758 |
164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67128950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001958_emphysema | 6.12967943 |
2 | MP0008995_early_reproductive_senescence | 4.89077806 |
3 | MP0005083_abnormal_biliary_tract | 4.34747048 |
4 | MP0008004_abnormal_stomach_pH | 4.10022245 |
5 | MP0001835_abnormal_antigen_presentation | 3.98101037 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.47596142 |
7 | MP0009785_altered_susceptibility_to | 3.32760772 |
8 | MP0001177_atelectasis | 3.22557079 |
9 | MP0003724_increased_susceptibility_to | 3.16448094 |
10 | MP0010368_abnormal_lymphatic_system | 3.15371642 |
11 | MP0005671_abnormal_response_to | 2.95882701 |
12 | MP0005388_respiratory_system_phenotype | 2.94418112 |
13 | MP0002133_abnormal_respiratory_system | 2.94418112 |
14 | MP0005000_abnormal_immune_tolerance | 2.88727409 |
15 | MP0001800_abnormal_humoral_immune | 2.82758544 |
16 | MP0006082_CNS_inflammation | 2.82116905 |
17 | MP0002295_abnormal_pulmonary_circulatio | 2.79927753 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.76539995 |
19 | MP0005025_abnormal_response_to | 2.70833598 |
20 | MP0002452_abnormal_antigen_presenting | 2.55505354 |
21 | MP0002723_abnormal_immune_serum | 2.55402514 |
22 | MP0000566_synostosis | 2.35783936 |
23 | MP0002419_abnormal_innate_immunity | 2.32247485 |
24 | MP0000537_abnormal_urethra_morphology | 2.31086313 |
25 | MP0003191_abnormal_cellular_cholesterol | 2.19587136 |
26 | MP0005167_abnormal_blood-brain_barrier | 2.15513222 |
27 | MP0010155_abnormal_intestine_physiology | 2.08458641 |
28 | MP0001819_abnormal_immune_cell | 2.03204454 |
29 | MP0004782_abnormal_surfactant_physiolog | 10.7311213 |
30 | MP0002420_abnormal_adaptive_immunity | 1.99579878 |
31 | MP0004947_skin_inflammation | 1.98959555 |
32 | MP0010234_abnormal_vibrissa_follicle | 1.98355363 |
33 | MP0001879_abnormal_lymphatic_vessel | 1.96161784 |
34 | MP0001845_abnormal_inflammatory_respons | 1.87685672 |
35 | MP0005310_abnormal_salivary_gland | 1.74873039 |
36 | MP0004510_myositis | 1.73629650 |
37 | MP0005451_abnormal_body_composition | 1.71311025 |
38 | MP0001348_abnormal_lacrimal_gland | 1.65103596 |
39 | MP0001533_abnormal_skeleton_physiology | 1.64000244 |
40 | MP0008469_abnormal_protein_level | 1.61216087 |
41 | MP0000716_abnormal_immune_system | 1.54759309 |
42 | MP0009764_decreased_sensitivity_to | 1.53258335 |
43 | MP0002166_altered_tumor_susceptibility | 1.52428603 |
44 | MP0002132_abnormal_respiratory_system | 1.51815089 |
45 | MP0004272_abnormal_basement_membrane | 1.51395228 |
46 | MP0005058_abnormal_lysosome_morphology | 1.44437960 |
47 | MP0001175_abnormal_lung_morphology | 1.42665618 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.36594100 |
49 | MP0001853_heart_inflammation | 1.33688907 |
50 | MP0003950_abnormal_plasma_membrane | 1.31168678 |
51 | MP0003115_abnormal_respiratory_system | 1.31067733 |
52 | MP0002998_abnormal_bone_remodeling | 1.30905623 |
53 | MP0002398_abnormal_bone_marrow | 1.29798282 |
54 | MP0001542_abnormal_bone_strength | 1.26723968 |
55 | MP0003786_premature_aging | 1.22698571 |
56 | MP0002006_tumorigenesis | 1.22583676 |
57 | MP0003763_abnormal_thymus_physiology | 1.22340728 |
58 | MP0003566_abnormal_cell_adhesion | 1.20906221 |
59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19271069 |
60 | MP0001545_abnormal_hematopoietic_system | 1.16968541 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.16968541 |
62 | MP0002429_abnormal_blood_cell | 1.16783525 |
63 | MP0002332_abnormal_exercise_endurance | 1.16076656 |
64 | MP0002163_abnormal_gland_morphology | 1.11151847 |
65 | MP0003690_abnormal_glial_cell | 1.10559231 |
66 | MP0000534_abnormal_ureter_morphology | 1.09548290 |
67 | MP0002277_abnormal_respiratory_mucosa | 1.09502877 |
68 | MP0010678_abnormal_skin_adnexa | 1.09226013 |
69 | MP0009840_abnormal_foam_cell | 1.09054577 |
70 | MP0001851_eye_inflammation | 1.03582075 |
71 | MP0009763_increased_sensitivity_to | 1.02824529 |
72 | MP0003172_abnormal_lysosome_physiology | 1.02634166 |
73 | MP0005085_abnormal_gallbladder_physiolo | 1.01622023 |
74 | MP0005275_abnormal_skin_tensile | 1.00220474 |
75 | MP0003045_fibrosis | 1.00182040 |
76 | MP0010352_gastrointestinal_tract_polyps | 0.99663458 |
77 | MP0004883_abnormal_blood_vessel | 0.98885640 |
78 | MP0005408_hypopigmentation | 0.97605478 |
79 | MP0000689_abnormal_spleen_morphology | 0.97008880 |
80 | MP0002722_abnormal_immune_system | 0.96547800 |
81 | MP0002139_abnormal_hepatobiliary_system | 0.94055863 |
82 | MP0005164_abnormal_response_to | 0.93693464 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.93629534 |
84 | MP0000343_altered_response_to | 0.93627447 |
85 | MP0002098_abnormal_vibrissa_morphology | 0.90933308 |
86 | MP0005166_decreased_susceptibility_to | 0.89386110 |
87 | MP0000858_altered_metastatic_potential | 0.88403140 |
88 | MP0006054_spinal_hemorrhage | 0.87542073 |
89 | MP0000462_abnormal_digestive_system | 0.87475185 |
90 | MP0005023_abnormal_wound_healing | 0.86272518 |
91 | MP0001943_abnormal_respiration | 0.86173018 |
92 | MP0004185_abnormal_adipocyte_glucose | 0.85597628 |
93 | MP0000249_abnormal_blood_vessel | 0.85515635 |
94 | MP0002118_abnormal_lipid_homeostasis | 0.83615166 |
95 | MP0002909_abnormal_adrenal_gland | 0.82876249 |
96 | MP0002254_reproductive_system_inflammat | 0.82786716 |
97 | MP0001666_abnormal_nutrient_absorption | 0.82424937 |
98 | MP0005464_abnormal_platelet_physiology | 0.82363621 |
99 | MP0003656_abnormal_erythrocyte_physiolo | 0.82113631 |
100 | MP0005623_abnormal_meninges_morphology | 0.81716306 |
101 | MP0005595_abnormal_vascular_smooth | 0.81663053 |
102 | MP0000767_abnormal_smooth_muscle | 0.81519478 |
103 | MP0001664_abnormal_digestion | 0.81312918 |
104 | MP0002405_respiratory_system_inflammati | 0.81026963 |
105 | MP0002796_impaired_skin_barrier | 0.80373005 |
106 | MP0000383_abnormal_hair_follicle | 0.79622507 |
107 | MP0003303_peritoneal_inflammation | 0.79425532 |
108 | MP0006138_congestive_heart_failure | 0.78263723 |
109 | MP0001873_stomach_inflammation | 0.77770312 |
110 | MP0000604_amyloidosis | 0.77727249 |
111 | MP0003279_aneurysm | 0.76220215 |
112 | MP0003453_abnormal_keratinocyte_physiol | 0.74097933 |
113 | MP0002234_abnormal_pharynx_morphology | 0.74006089 |
114 | MP0010329_abnormal_lipoprotein_level | 0.73675654 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.71358986 |
116 | MP0003091_abnormal_cell_migration | 0.69567877 |
117 | MP0001346_abnormal_lacrimal_gland | 0.68291195 |
118 | MP0003436_decreased_susceptibility_to | 0.66327464 |
119 | MP0005165_increased_susceptibility_to | 0.66007996 |
120 | MP0003448_altered_tumor_morphology | 0.64242567 |
121 | MP0008874_decreased_physiological_sensi | 0.63737418 |
122 | MP0003705_abnormal_hypodermis_morpholog | 0.63605405 |
123 | MP0009278_abnormal_bone_marrow | 0.63549123 |
124 | MP0004808_abnormal_hematopoietic_stem | 0.63260381 |
125 | MP0003300_gastrointestinal_ulcer | 0.63239318 |
126 | MP0003075_altered_response_to | 0.61040522 |
127 | MP0000627_abnormal_mammary_gland | 0.60386423 |
128 | MP0005390_skeleton_phenotype | 0.59508137 |
129 | MP0003866_abnormal_defecation | 0.59414214 |
130 | MP0003329_amyloid_beta_deposits | 0.59013796 |
131 | MP0000681_abnormal_thyroid_gland | 0.58211441 |
132 | MP0003828_pulmonary_edema | 0.57431348 |
133 | MP0002128_abnormal_blood_circulation | 0.57335004 |
134 | MP0005379_endocrine/exocrine_gland_phen | 0.56506628 |
135 | MP0010030_abnormal_orbit_morphology | 0.56020870 |
136 | MP0001501_abnormal_sleep_pattern | 0.55957274 |
137 | MP0008438_abnormal_cutaneous_collagen | 0.54516729 |
138 | MP0002925_abnormal_cardiovascular_devel | 0.54324025 |
139 | MP0003890_abnormal_embryonic-extraembry | 0.53514600 |
140 | MP0004858_abnormal_nervous_system | 0.53464327 |
141 | MP0000639_abnormal_adrenal_gland | 0.52893948 |
142 | MP0002282_abnormal_trachea_morphology | 0.52725019 |
143 | MP0008961_abnormal_basal_metabolism | 0.52269383 |
144 | MP0005076_abnormal_cell_differentiation | 0.50653363 |
145 | MP0002877_abnormal_melanocyte_morpholog | 0.50517358 |
146 | MP0001614_abnormal_blood_vessel | 0.50329310 |
147 | MP0003119_abnormal_digestive_system | 0.49761350 |
148 | MP0000470_abnormal_stomach_morphology | 0.49628285 |
149 | MP0001849_ear_inflammation | 0.48809771 |
150 | MP0000685_abnormal_immune_system | 0.48761321 |
151 | MP0002168_other_aberrant_phenotype | 0.48297011 |
152 | MP0003638_abnormal_response/metabolism_ | 0.45521481 |
153 | MP0004084_abnormal_cardiac_muscle | 0.45457341 |
154 | MP0001790_abnormal_immune_system | 0.44581611 |
155 | MP0005387_immune_system_phenotype | 0.44581611 |
156 | MP0005647_abnormal_sex_gland | 0.44519235 |
157 | MP0009643_abnormal_urine_homeostasis | 0.44403173 |
158 | MP0004130_abnormal_muscle_cell | 0.44069467 |
159 | MP0008260_abnormal_autophagy | 0.43885796 |
160 | MP0002136_abnormal_kidney_physiology | 0.43017517 |
161 | MP0001440_abnormal_grooming_behavior | 0.41572275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Tubulointerstitial fibrosis (HP:0005576) | 7.02569373 |
2 | Tachypnea (HP:0002789) | 6.98189608 |
3 | Respiratory distress (HP:0002098) | 6.29181876 |
4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.93054625 |
5 | Gout (HP:0001997) | 5.56698587 |
6 | Renal salt wasting (HP:0000127) | 5.43437602 |
7 | Chronic bronchitis (HP:0004469) | 5.08474585 |
8 | Neurofibrillary tangles (HP:0002185) | 4.78655747 |
9 | Gastrointestinal infarctions (HP:0005244) | 4.67232892 |
10 | Polycythemia (HP:0001901) | 4.32444445 |
11 | Eczematoid dermatitis (HP:0000976) | 4.26830471 |
12 | Systemic lupus erythematosus (HP:0002725) | 4.22808459 |
13 | Retrobulbar optic neuritis (HP:0100654) | 4.18682319 |
14 | Optic neuritis (HP:0100653) | 4.18682319 |
15 | Onycholysis (HP:0001806) | 4.07661743 |
16 | Tubulointerstitial abnormality (HP:0001969) | 4.01334761 |
17 | Ulnar bowing (HP:0003031) | 4.00885574 |
18 | Vasculitis (HP:0002633) | 3.95509008 |
19 | Orchitis (HP:0100796) | 3.93697671 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.88669475 |
21 | Tubulointerstitial nephritis (HP:0001970) | 3.86465903 |
22 | Cerebral inclusion bodies (HP:0100314) | 3.86147218 |
23 | Recurrent abscess formation (HP:0002722) | 3.79569300 |
24 | Hypergammaglobulinemia (HP:0010702) | 3.75849927 |
25 | Hemoptysis (HP:0002105) | 3.71192987 |
26 | Mediastinal lymphadenopathy (HP:0100721) | 3.65055902 |
27 | Hematochezia (HP:0002573) | 3.64856505 |
28 | Hyperkalemia (HP:0002153) | 3.62326047 |
29 | Alveolar cell carcinoma (HP:0006519) | 3.52155912 |
30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.51137125 |
31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.51137125 |
32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.51137125 |
33 | Broad metatarsal (HP:0001783) | 3.47252393 |
34 | Gastrointestinal stroma tumor (HP:0100723) | 3.46653684 |
35 | Myositis (HP:0100614) | 3.45748477 |
36 | Recurrent viral infections (HP:0004429) | 3.43852193 |
37 | Thyroid-stimulating hormone excess (HP:0002925) | 3.42848462 |
38 | Increased IgM level (HP:0003496) | 3.41481583 |
39 | Pulmonary infiltrates (HP:0002113) | 3.40218995 |
40 | Glomerulonephritis (HP:0000099) | 3.39576060 |
41 | Visceral angiomatosis (HP:0100761) | 3.35951515 |
42 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.31713450 |
43 | Chronic otitis media (HP:0000389) | 3.26904208 |
44 | Recurrent bronchitis (HP:0002837) | 3.26071099 |
45 | Abnormality of the nasal mucosa (HP:0000433) | 3.23007697 |
46 | Colitis (HP:0002583) | 3.21184083 |
47 | Keratoconjunctivitis sicca (HP:0001097) | 3.19727874 |
48 | Increased IgE level (HP:0003212) | 3.17786131 |
49 | Recurrent fungal infections (HP:0002841) | 3.16314019 |
50 | Hemangiomatosis (HP:0007461) | 3.15315541 |
51 | Autoimmune thrombocytopenia (HP:0001973) | 3.14943772 |
52 | Gangrene (HP:0100758) | 3.12800486 |
53 | Abnormality of the fingertips (HP:0001211) | 3.11480731 |
54 | Neonatal respiratory distress (HP:0002643) | 3.07123731 |
55 | Recurrent cutaneous fungal infections (HP:0011370) | 3.06868029 |
56 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.06868029 |
57 | Supranuclear gaze palsy (HP:0000605) | 3.05503130 |
58 | Spontaneous hematomas (HP:0007420) | 2.97320643 |
59 | Long toe (HP:0010511) | 2.96373286 |
60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95502509 |
61 | Tubular atrophy (HP:0000092) | 2.94481653 |
62 | Keratoconjunctivitis (HP:0001096) | 2.92675461 |
63 | Hypertensive crisis (HP:0100735) | 2.89113977 |
64 | IgA deficiency (HP:0002720) | 2.86735360 |
65 | Recurrent skin infections (HP:0001581) | 2.86375025 |
66 | Hypotension (HP:0002615) | 2.83259700 |
67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82224627 |
68 | Bowed forearm bones (HP:0003956) | 2.82173411 |
69 | Bowing of the arm (HP:0006488) | 2.82173411 |
70 | Stomach cancer (HP:0012126) | 2.80800684 |
71 | Loss of speech (HP:0002371) | 2.79631136 |
72 | Meningitis (HP:0001287) | 2.77747662 |
73 | Hyperaldosteronism (HP:0000859) | 2.72498769 |
74 | Abnormality of chloride homeostasis (HP:0011422) | 2.69707026 |
75 | Joint swelling (HP:0001386) | 2.65788219 |
76 | Vacuolated lymphocytes (HP:0001922) | 2.63257033 |
77 | Emphysema (HP:0002097) | 2.62365599 |
78 | Amaurosis fugax (HP:0100576) | 2.60764349 |
79 | Chest pain (HP:0100749) | 2.60060467 |
80 | Esophageal varix (HP:0002040) | 2.59307673 |
81 | Autoimmune hemolytic anemia (HP:0001890) | 2.57940956 |
82 | Premature loss of primary teeth (HP:0006323) | 2.57372302 |
83 | Cerebral aneurysm (HP:0004944) | 2.53628277 |
84 | Bronchomalacia (HP:0002780) | 2.52555260 |
85 | Agammaglobulinemia (HP:0004432) | 2.51067130 |
86 | Bronchitis (HP:0012387) | 2.50575959 |
87 | Stenosis of the external auditory canal (HP:0000402) | 2.47831680 |
88 | Dysostosis multiplex (HP:0000943) | 2.46506551 |
89 | Pulmonary fibrosis (HP:0002206) | 2.46190941 |
90 | Abnormality of T cell number (HP:0011839) | 2.46011266 |
91 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.44169044 |
92 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.44169044 |
93 | Single umbilical artery (HP:0001195) | 2.44169044 |
94 | Inflammation of the large intestine (HP:0002037) | 2.43719578 |
95 | Complement deficiency (HP:0004431) | 2.43191517 |
96 | Increased purine levels (HP:0004368) | 2.40361461 |
97 | Hyperuricemia (HP:0002149) | 2.40361461 |
98 | Megalencephaly (HP:0001355) | 2.40322887 |
99 | Glomerulosclerosis (HP:0000096) | 2.39568424 |
100 | Turricephaly (HP:0000262) | 2.33820271 |
101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32934410 |
102 | T lymphocytopenia (HP:0005403) | 2.32473594 |
103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32041710 |
104 | Osteolytic defects of the hand bones (HP:0009699) | 2.32041710 |
105 | Fragile nails (HP:0001808) | 2.31808724 |
106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31772369 |
107 | Subacute progressive viral hepatitis (HP:0006572) | 2.29471646 |
108 | Stomatitis (HP:0010280) | 2.29280218 |
109 | Encephalitis (HP:0002383) | 2.28961705 |
110 | Aplasia involving bones of the extremities (HP:0009825) | 2.27536617 |
111 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.27536617 |
112 | Aplasia of the phalanges of the hand (HP:0009802) | 2.27536617 |
113 | Gastrointestinal inflammation (HP:0004386) | 2.26650509 |
114 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.26235989 |
115 | Anorexia (HP:0002039) | 2.24674460 |
116 | Arterial thrombosis (HP:0004420) | 2.22059108 |
117 | Nasal polyposis (HP:0100582) | 2.21064163 |
118 | Increased cerebral lipofuscin (HP:0011813) | 2.20573559 |
119 | Malnutrition (HP:0004395) | 2.19658226 |
120 | Arthralgia (HP:0002829) | 2.19556302 |
121 | Nephritis (HP:0000123) | 2.18843573 |
122 | Abnormality of the pleura (HP:0002103) | 2.18713280 |
123 | Humeroradial synostosis (HP:0003041) | 2.18676175 |
124 | Synostosis involving the elbow (HP:0003938) | 2.18676175 |
125 | Recurrent sinusitis (HP:0011108) | 2.18243281 |
126 | Rapidly progressive (HP:0003678) | 2.17656381 |
127 | Pulmonary hypertension (HP:0002092) | 2.15848600 |
128 | Shallow orbits (HP:0000586) | 2.14008252 |
129 | Gingivitis (HP:0000230) | 2.12388138 |
130 | Atrophic scars (HP:0001075) | 2.12173869 |
131 | Abnormality of the endocardium (HP:0004306) | 2.10438047 |
132 | Milia (HP:0001056) | 2.09815403 |
133 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09699597 |
134 | Abnormality of complement system (HP:0005339) | 2.09640381 |
135 | Abnormality of macrophages (HP:0004311) | 2.08818063 |
136 | Lymphopenia (HP:0001888) | 2.07261560 |
137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06371261 |
138 | Xerostomia (HP:0000217) | 2.06248947 |
139 | Partial duplication of thumb phalanx (HP:0009944) | 2.06189924 |
140 | Chronic diarrhea (HP:0002028) | 2.05948386 |
141 | Urticaria (HP:0001025) | 2.05803377 |
142 | Leukocytosis (HP:0001974) | 2.05448703 |
143 | Exertional dyspnea (HP:0002875) | 2.04919449 |
144 | Disinhibition (HP:0000734) | 2.04881396 |
145 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04131608 |
146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04131608 |
147 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04131608 |
148 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03512242 |
149 | Mucopolysacchariduria (HP:0008155) | 2.03512242 |
150 | Abnormality of the prostate (HP:0008775) | 2.02791464 |
151 | Pulmonary embolism (HP:0002204) | 2.02564131 |
152 | Decreased circulating renin level (HP:0003351) | 2.01924206 |
153 | Growth hormone excess (HP:0000845) | 2.01530490 |
154 | Interstitial pulmonary disease (HP:0006530) | 15.2422994 |
155 | Split foot (HP:0001839) | 1.97829935 |
156 | Hyponatremia (HP:0002902) | 1.96692504 |
157 | Abnormality of the 2nd finger (HP:0004100) | 1.95848234 |
158 | Broad distal phalanx of finger (HP:0009836) | 1.92971365 |
159 | Conjunctival telangiectasia (HP:0000524) | 1.88945474 |
160 | Abnormality of purine metabolism (HP:0004352) | 1.88176833 |
161 | Thickened helices (HP:0000391) | 1.85176868 |
162 | Prolonged neonatal jaundice (HP:0006579) | 1.84269896 |
163 | Cerebral hemorrhage (HP:0001342) | 1.81936915 |
164 | Deep venous thrombosis (HP:0002625) | 1.77949942 |
165 | Partial duplication of the phalanx of hand (HP:0009999) | 1.74065501 |
166 | Potter facies (HP:0002009) | 1.71998695 |
167 | Facial shape deformation (HP:0011334) | 1.71998695 |
168 | Buphthalmos (HP:0000557) | 1.71083969 |
169 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.70733771 |
170 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70204071 |
171 | Microcytic anemia (HP:0001935) | 1.70129725 |
172 | Pustule (HP:0200039) | 1.69838898 |
173 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67443227 |
174 | Overriding aorta (HP:0002623) | 1.67045457 |
175 | Resting tremor (HP:0002322) | 1.64736070 |
176 | Hypokalemic alkalosis (HP:0001949) | 1.64274642 |
177 | Rectal prolapse (HP:0002035) | 1.60436659 |
178 | Adrenal overactivity (HP:0002717) | 1.59587699 |
179 | Plantar hyperkeratosis (HP:0007556) | 1.59257123 |
180 | Cavernous hemangioma (HP:0001048) | 1.56002922 |
181 | Restrictive lung disease (HP:0002091) | 1.54785380 |
182 | Coronal craniosynostosis (HP:0004440) | 1.53785269 |
183 | Progressive sensorineural hearing impairment (HP:0000408) | 1.53746358 |
184 | Abnormality of sodium homeostasis (HP:0010931) | 1.53390492 |
185 | Hyperpituitarism (HP:0010514) | 1.53311123 |
186 | Hypoplasia of dental enamel (HP:0006297) | 1.53096868 |
187 | Premature skin wrinkling (HP:0100678) | 1.52927353 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR2 | 5.46894457 |
2 | STK24 | 4.81039711 |
3 | TIE1 | 4.65699866 |
4 | MAP3K14 | 3.98858808 |
5 | LRRK2 | 3.49217652 |
6 | PRPF4B | 3.23925834 |
7 | ZAP70 | 2.99917851 |
8 | JAK3 | 2.99167215 |
9 | RIPK4 | 2.94810445 |
10 | TGFBR2 | 2.94482991 |
11 | IKBKE | 2.91359775 |
12 | IRAK3 | 2.89323193 |
13 | GRK7 | 2.75192553 |
14 | TRIB3 | 2.57643667 |
15 | PAK4 | 2.51947791 |
16 | EPHB1 | 2.49281623 |
17 | EPHA2 | 2.42637087 |
18 | MAP4K1 | 2.39978895 |
19 | MST4 | 2.31664644 |
20 | DAPK2 | 2.30984943 |
21 | LMTK2 | 2.29372046 |
22 | RIPK1 | 2.28186600 |
23 | PDGFRB | 2.10464499 |
24 | ILK | 2.06721284 |
25 | IKBKB | 2.02304804 |
26 | IRAK4 | 1.96391633 |
27 | KIT | 1.95742364 |
28 | MAP3K13 | 1.83223905 |
29 | FER | 1.79229359 |
30 | EPHB2 | 1.77926880 |
31 | FGFR4 | 1.76940002 |
32 | MST1R | 1.71653057 |
33 | STK10 | 1.65440715 |
34 | MAPK15 | 1.65094011 |
35 | IRAK1 | 1.54675005 |
36 | MAP3K2 | 1.50752735 |
37 | MAP3K9 | 1.45771010 |
38 | ERN1 | 1.44710901 |
39 | PTK6 | 1.42951794 |
40 | MAP3K3 | 1.37292697 |
41 | GRK1 | 1.35248583 |
42 | BMPR2 | 1.34549087 |
43 | TESK1 | 1.32434177 |
44 | EPHA3 | 1.31251235 |
45 | CDK6 | 1.25349436 |
46 | ADRBK2 | 1.18762690 |
47 | TAOK3 | 1.18402857 |
48 | MET | 1.17659006 |
49 | PDGFRA | 1.15494237 |
50 | TXK | 1.14163440 |
51 | KSR2 | 1.13113962 |
52 | GSK3A | 1.10474353 |
53 | SYK | 1.10379939 |
54 | CAMK1D | 1.08340312 |
55 | SIK1 | 1.07819112 |
56 | FGFR3 | 1.06541029 |
57 | MYLK | 1.05198049 |
58 | LYN | 1.02451611 |
59 | CSF1R | 0.97716174 |
60 | TAOK2 | 0.96721088 |
61 | PIM2 | 0.95973990 |
62 | NLK | 0.92941721 |
63 | SIK3 | 0.89117856 |
64 | LATS1 | 0.86405045 |
65 | LIMK1 | 0.85669802 |
66 | EGFR | 0.84527312 |
67 | PRKD1 | 0.79526805 |
68 | CSK | 0.79184556 |
69 | LCK | 0.74682356 |
70 | BTK | 0.72878580 |
71 | FGFR1 | 0.71322044 |
72 | PTK2 | 0.68666980 |
73 | NTRK1 | 0.67416967 |
74 | MAPK7 | 0.65418153 |
75 | PKN2 | 0.65259196 |
76 | MOS | 0.65157937 |
77 | MAP2K2 | 0.65077671 |
78 | KDR | 0.64519084 |
79 | CLK1 | 0.63541382 |
80 | ERBB2 | 0.63119662 |
81 | DDR2 | 0.60481256 |
82 | MAP2K3 | 0.59818882 |
83 | PTK2B | 0.59014996 |
84 | HCK | 0.58726009 |
85 | MAPK11 | 0.58622227 |
86 | TGFBR1 | 0.58516477 |
87 | CAMK1G | 0.58423602 |
88 | MAP3K1 | 0.57869124 |
89 | PRKCQ | 0.57605494 |
90 | DAPK1 | 0.53396523 |
91 | PDPK1 | 0.51360878 |
92 | YES1 | 0.49754387 |
93 | NEK9 | 0.49149862 |
94 | DAPK3 | 0.48921321 |
95 | PRKG2 | 0.48473916 |
96 | BMX | 0.48468189 |
97 | PDK1 | 0.48273663 |
98 | MAP2K1 | 0.47915610 |
99 | MARK2 | 0.46806897 |
100 | ITK | 0.46667090 |
101 | RPS6KA5 | 0.46406688 |
102 | TTN | 0.45157707 |
103 | RPS6KA4 | 0.43977909 |
104 | JAK1 | 0.43346703 |
105 | INSR | 0.43069103 |
106 | MATK | 0.41515917 |
107 | MAP3K12 | 0.41180986 |
108 | CDK12 | 0.40274754 |
109 | PIM1 | 0.40267660 |
110 | TYRO3 | 0.38516571 |
111 | RET | 0.38491895 |
112 | HIPK2 | 0.37713845 |
113 | ABL1 | 0.37101176 |
114 | TEC | 0.37055247 |
115 | SIK2 | 0.36793828 |
116 | MAPKAPK2 | 0.36754646 |
117 | MAP3K5 | 0.35797229 |
118 | WNK4 | 0.35644001 |
119 | ROCK2 | 0.34877618 |
120 | IRAK2 | 0.34239481 |
121 | TYK2 | 0.34103708 |
122 | FGR | 0.33047855 |
123 | CHUK | 0.32493319 |
124 | DMPK | 0.32462196 |
125 | SGK3 | 0.32072434 |
126 | MAP3K7 | 0.31002427 |
127 | BLK | 0.30489487 |
128 | RPS6KA2 | 0.29928115 |
129 | NME2 | 0.29784336 |
130 | PRKCH | 0.29658821 |
131 | BRD4 | 0.29571188 |
132 | MAPK4 | 0.29380139 |
133 | TBK1 | 0.28201276 |
134 | MAPK3 | 0.27810701 |
135 | IGF1R | 0.27710809 |
136 | MARK3 | 0.27586500 |
137 | MELK | 0.26294797 |
138 | FYN | 0.26117563 |
139 | FES | 0.24527505 |
140 | ROCK1 | 0.24509212 |
141 | PKN1 | 0.23618130 |
142 | TAOK1 | 0.23032735 |
143 | PRKCD | 0.22907805 |
144 | SMG1 | 0.22554618 |
145 | EIF2AK2 | 0.21715405 |
146 | TRPM7 | 0.21503576 |
147 | JAK2 | 0.20918904 |
148 | PRKCE | 0.20810224 |
149 | STK39 | 0.20707858 |
150 | BCR | 0.20596748 |
151 | CDC42BPA | 0.19533655 |
152 | STK3 | 0.19020970 |
153 | DYRK1B | 0.18776385 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 4.11520937 |
2 | Mineral absorption_Homo sapiens_hsa04978 | 3.68766348 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.41998076 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.31862541 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20065121 |
6 | Asthma_Homo sapiens_hsa05310 | 3.15451020 |
7 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.06333605 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.98420372 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.83357463 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.82237540 |
11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.75350650 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62631120 |
13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.53520567 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.42183182 |
15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42178047 |
16 | Adherens junction_Homo sapiens_hsa04520 | 2.35327458 |
17 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.34407334 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.26369218 |
19 | Influenza A_Homo sapiens_hsa05164 | 2.13863960 |
20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06846568 |
21 | Phagosome_Homo sapiens_hsa04145 | 2.04698847 |
22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.94780215 |
23 | Measles_Homo sapiens_hsa05162 | 1.93951371 |
24 | Tight junction_Homo sapiens_hsa04530 | 1.92511374 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83861969 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82942630 |
27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73942239 |
28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.72825794 |
29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.68676506 |
30 | * Lysosome_Homo sapiens_hsa04142 | 1.67774366 |
31 | Focal adhesion_Homo sapiens_hsa04510 | 1.62504406 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.61900063 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58397458 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55791885 |
35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.53994690 |
36 | Bladder cancer_Homo sapiens_hsa05219 | 1.52660940 |
37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50050102 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47727898 |
39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.44931893 |
40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44608439 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42682920 |
42 | Malaria_Homo sapiens_hsa05144 | 1.41046392 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.37476667 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33973661 |
45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.32946760 |
46 | Amoebiasis_Homo sapiens_hsa05146 | 1.32854741 |
47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32629188 |
48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32602981 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.31848542 |
50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30272369 |
51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24924944 |
52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22981591 |
53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22066699 |
54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21312866 |
55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.18573062 |
56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17491980 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16024088 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15623372 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14374248 |
60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.10873790 |
61 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08461101 |
62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06090494 |
63 | Hepatitis B_Homo sapiens_hsa05161 | 1.05555406 |
64 | Platelet activation_Homo sapiens_hsa04611 | 1.02315705 |
65 | Endocytosis_Homo sapiens_hsa04144 | 1.01272490 |
66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.01243683 |
67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00084170 |
68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99804794 |
69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98902653 |
70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92940836 |
71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91832028 |
72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90918569 |
73 | Axon guidance_Homo sapiens_hsa04360 | 0.89899408 |
74 | Renin secretion_Homo sapiens_hsa04924 | 0.89610937 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89126405 |
76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86337450 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85829945 |
78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85757098 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84512972 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83966923 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83891853 |
82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81683639 |
83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81649748 |
84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80184384 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.79856791 |
86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79674817 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.78011252 |
88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77560428 |
89 | Taste transduction_Homo sapiens_hsa04742 | 0.77269276 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75429533 |
91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73635301 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73316275 |
93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73285503 |
94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72203091 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.71988420 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.71817025 |
97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70310060 |
98 | Salivary secretion_Homo sapiens_hsa04970 | 0.70177895 |
99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70003369 |
100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69420997 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67465962 |
102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66914529 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64780147 |
104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64280628 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64016194 |
106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62804258 |
107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61290047 |
108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59261797 |
109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58397681 |
110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54034342 |
111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53810470 |
112 | Apoptosis_Homo sapiens_hsa04210 | 0.53790622 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53179021 |
114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52077407 |
115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51539199 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.51398491 |
117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51178053 |
118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49823922 |
119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48458030 |
120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48354642 |
121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48121526 |
122 | Shigellosis_Homo sapiens_hsa05131 | 0.47920567 |
123 | Peroxisome_Homo sapiens_hsa04146 | 0.44787155 |
124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44169537 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43841763 |
126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43519124 |
127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42475409 |
128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41185075 |
129 | Prostate cancer_Homo sapiens_hsa05215 | 0.40057725 |
130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39858996 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38934132 |
132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37787450 |
133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37170280 |
134 | Melanoma_Homo sapiens_hsa05218 | 0.37142372 |
135 | Tuberculosis_Homo sapiens_hsa05152 | 0.37091179 |
136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36670781 |
137 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36134378 |
138 | Melanogenesis_Homo sapiens_hsa04916 | 0.35879756 |
139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35578212 |
140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34566364 |
141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29810505 |
142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24468092 |
143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21422546 |
144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21392611 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19466544 |
146 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.18482817 |
147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16417191 |
148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14927627 |
149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11601471 |
150 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.11588339 |
151 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10041197 |
152 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.09525781 |
153 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05018010 |